GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (NEOE:CYBN) » Definitions » Cash Receipts from Fees and Commissions

Cybin (NEOE:CYBN) Cash Receipts from Fees and Commissions


View and export this data going back to 2020. Start your Free Trial

What is Cybin Cash Receipts from Fees and Commissions?

Cash Receipts from Fees and Commissions only applicable to companies reporting Cash Flow from Operations in direct method.


Cybin Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (NEOE:CYBN) » Definitions » Cash Receipts from Fees and Commissions
Traded in Other Exchanges
Address
100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.
Executives
Gabriel Fahel Senior Officer
Gregory Joseph Cavers Senior Officer
Douglas Lee Drysdale Senior Officer
Paul Glavine 10% Security Holder, Director, Senior Officer
Eric So 10% Security Holder, Director, Senior Officer
Aaron Frank Bartlone Senior Officer